You just read:

Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients

News provided by

Shenzhen Chipscreen Biosciences, Ltd.

Feb 17, 2019, 21:08 ET